/
/
Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans
A subscription to JoVE is required to view this content. Sign in or start your free trial.
2,860 Views
•
04:48 min
•
March 24, 2022
DOI:
1Institute of Clinical Medicine, College of Medicine,National Cheng Kung University, 2Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine,National Cheng Kung University, 3Department of Dermatology, National Cheng Kung University Hospital, College of Medicine,National Cheng Kung University, 4Department of Microbiology and Immunology, College of Medicine,National Cheng Kung University, 5Department of Dermatology, Fu Jen Catholic University Hospital,Fu Jen Catholic University, 6Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine,National Cheng Kung University, 7School of Medicine,National Cheng Kung University, 8Department of Biochemistry and Molecular Biology, College of Medicine,National Cheng Kung University, 9Center of Applied Nanomedicine,National Cheng Kung University
Summary
Automatically generated
The growing incidence of drug-resistant Candida albicans is a serious health issue worldwide. Antimicrobial photodynamic therapy (aPDT) may offer a strategy to fight against drug-resistant fungal infections. The present protocol describes Rose bengal-mediated aPDT efficacy on a multidrug-resistant C. albicans strain in vitro.
Read Article
Cite this Article
Hung, J., Wang, Z., Lo, Y., Lee, C., Chang, Y., Chang, R. Y., Huang, C., Wong, T. Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans. J. Vis. Exp. (181), e63558, doi:10.3791/63558 (2022).
Copy